TUCSON, Ariz., March 21, 2025 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX), an innovator in rapid in vitro diagnostics for microbiology, today announced the submission of its Accelerate ...
In a recent earnings call, Accelerate Diagnostics (NASDAQ:AXDX) reported a decrease in net sales to $3 million for the quarter and $12.1 million year-to-date, compared to last year's figures. The ...
TUCSON, Ariz. – Accelerate Diagnostics, Inc. (NASDAQ:AXDX), a company specializing in rapid in vitro diagnostics with a current market capitalization of $28 million, has announced the submission of ...
TUCSON, Ariz., March 8, 2023 /PRNewswire/ -- Accelerate Diagnostics, Inc. (AXDX) a disruptor in bloodstream infection identification and susceptibility testing today announced the appointment of Hany ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results